This trial is active not recruiting!
Search for a recruiting clinical trial for your condition
You can access this
clinical trial
if you have
Postoperative Pain
and you are
between 18 and 120
years old
Phase
4
The primary goal of this phase is to monitor the long-term effects.
The treatment is already on the market.
Show me locations

The purpose

The purpose of this study is to assess the use of intravenous Acetaminophen (OFIRMEV) as an effective adjunct therapeutic agent in patients undergoing craniotomy.

Provided treatments

  • Drug: Acetaminophen
  • Drug: Placebo
Tris trial is registered with FDA with number: NCT01598701. The sponsor of the trial is The University of Texas Health Science Center, Houston and it is looking for 100 volunteers for the current phase.
Official trial title:
The Opioid-Sparing and Analgesic Effects of IV Acetaminophen in Craniotomy: A Prospective, Randomized, Placebo-Controlled, Double-Blind Study